Supriya D. Mahajan has established herself as an investigator in the area of neuropathogenesis of HIV-1 in the context of drug abuse. She has initiated several new projects that investigate the role of a unique key signaling molecule in the dopaminergic pathway that impacts drug addiction, depression and other neurological disorders. Her focus has always been on collaborative, interdisciplinary partnerships between various Departments within UB that include the Institute of Lasers, Photonics and Biophotonics, Research Institute of Addiction, Dept of Computer Science and Engineering, Dept of Pharmaceutical sciences and the Department of Bioengineering. Education and Training: Postdoctoral Fellow, Immunology, University at Buffalo, The State University of New York (2001); Postdoctoral Fellow, Metabolism/Endocrinology, Case Western Reserve University (CWRU) (1998); PhD, Metabolism/Endocrinology, All India Institute of Medical Sciences (AIIMS) (1995); MD, University of Bombay, India (1987); BS, University of Bombay, India (1985). Dr. Mahajan is Director of Research of the Division of Allergy, Immunology & Rheumatology. She supervises the research training of the Allergy fellows,Medical residents, graduate and undergraduate students. Dr. Mahajan has presented her research work at National and International conferences and was an invited speaker at several seminars and colloquiums. She is a reviewer and an adhoc member of the editorial board of several journals in her field.

Apoptosis and cell death; Bioinformatics; Endocrinology; Gene Expression; Gene therapy; Genomics and proteomics; Immunology; Molecular and Cellular Biology; Molecular Basis of Disease; Neurobiology; RNA; Viral Pathogenesis